DLA Piper advised Akoya Biosciences on the deal. Akoya Biosciences (Akoya), a leading biotechnology company that specializes in the development and commercialization of spatial biology solutions,...
Akoya Biosciences’ $43.5 Million Common Stock Offering
Skyward Specialty’s $134 Million Upsized Initial Public Offering
DLA Piper advised Skyward Specialty, while Latham & Watkins LLP represented the underwriters in the offering. Skyward Specialty Insurance Group, Inc., a specialty insurance company, delivering...